Longitudinal changes in chemerin and their effect on outcomes, mechanisms of adiposopathy between chemerin and adiponectin, and distribution of body adipose tissue in prevalent HD patients warrant future detailed studies. This evidence concerns the gene RARRES2 and Huntington disease.